ANTX logo

AN2 Therapeutics, Inc. (ANTX)

Profile

Full Name

AN2 Therapeutics, Inc.

Ticker

NASDAQ: ANTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 25, 2022

Indexes

Not included

Website

https://www.an2therapeutics.com

Employees

22

Key Details

Price

$1.15(+3.60%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$1.72(+37.23% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.15
    ANTX price is $1.15

    30-Day Relative Volume

    0.64
    ANTX 30-day relative volume is 0.64

    Price Performance

    Price Today change

    +3.6%
    ANTX price is up +3.6% today

    Price YTD change

    -16.67%
    ANTX price is down -16.67% since January 1st

    Price 1-year change

    +3.6%
    ANTX price is up +3.6% year-on-year

    Price 3-year change

    -93.43%
    ANTX price is down -93.43% over the past 3 years

    Price Range

    Price All-time high

    $23.58
    ANTX price is currently -95.12% below its historical high of $23.58

    Price 3-year low

    $0.87
    ANTX price is currently +32.18% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $31.43M
    ANTX market capitalization is $31.43 million

    Market cap 3-year change

    -90.75%
    ANTX market capitalization is down -90.75% over the past 3 years

    Market cap All-time high

    $640.33M
    ANTX market capitalization is currently -95.09% below its historical high of $640.33 million

    Market cap sector rank

    27.72%
    ANTX market capitalization is higher than 27.72% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -8.43%
    ANTX shares outstanding is down -8.43% year-on-year

    Shares Outstanding 3-Year Change

    +40.84%
    ANTX shares outstanding is up +40.84% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.65
    ANTX beta is 0.65

    200-day SMA

    $1.15
    ANTX price is currently equal to its 200-day simple moving average

    50-day SMA

    $1.15
    ANTX price is currently equal to its 50-day simple moving average

    RSI

    55.23
    ANTX 14-day relative strength index is 55.23

    Volume

    0.64
    ANTX 30-day relative volume is 0.64

    ATR

    $0.07
    ANTX average true range is $0.07

    10-day Historical Volatility

    39.32%
    ANTX 10-day historical volatility is 39.32%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    ANTX annual revenue is $0.00

    Revenue Analysts estimate

    -
    ANTX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    ANTX annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.61%
    ANTX annual revenue is higher than 28.61% of companies in Healthcare sector

    EPS

    EPS

    -$1.72
    ANTX annual earnings per share is -$1.72

    EPS Analysts estimate

    -$1.01
    ANTX annual earnings per share is currently +70.30% higher than the consensus analysts' forecast

    EPS 1-year change

    +37.23%
    ANTX annual earnings per share is up +37.23% year-on-year

    EPS Sector rank

    39.29%
    ANTX annual earnings per share is higher than 39.29% of companies in Healthcare sector

    Profit

    Gross profit

    $0.00
    ANTX annual gross profit is $0.00

    Gross margin

    -
    ANTX annual gross profit margin value is unknown

    Operating profit

    -$54.55M
    ANTX annual operating income is -$54.55 million

    Operating margin

    -
    ANTX annual operating profit margin value is unknown

    Net income

    -$51.32M
    ANTX annual net profit is -$51.32 million

    Net margin

    -
    ANTX annual net profit margin value is unknown

    Expenses

    Total expenses

    $51.32M
    ANTX annual total expenses is $51.32 million

    Operating expenses

    $54.55M
    ANTX annual total operating expenses is $54.55 million

    Cost of goods sold

    $0.00
    ANTX annual cost of goods sold is $0.00

    Selling, general & administrative expenses

    $0.00
    ANTX annual SGA is $0.00

    Depreciation and amortization

    -
    ANTX annual depreciation & amortization value is unknown

    Interest expense

    $0.00
    ANTX annual interest expense is $0.00

    Income tax

    $0.00
    ANTX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$54.55M
    ANTX annual earnings before interest & taxes is -$54.55 million

    EBITDA

    -$54.55M
    ANTX annual EBITDA is -$54.55 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $92.09M
    ANTX annual total assets is $92.09 million

    Non current assets

    $5.83M
    ANTX annual long term assets is $5.83 million

    Current assets

    $86.26M
    ANTX annual total current assets is $86.26 million

    Cash and cash equivalents

    $83.62M
    ANTX annual cash & cash equivalents is $83.62 million

    Accounts receivable

    $0.00
    ANTX annual accounts receivable is $0.00

    Inventory

    $0.00
    ANTX annual inventory is $0.00

    Liabilities

    Total liabilities

    $10.24M
    ANTX annual total liabilities is $10.24 million

    Long term liabilities

    $0.00
    ANTX annual total long term liabilities is $0.00

    Current liabilities

    $10.24M
    ANTX annual total current liabilities is $10.24 million

    Accounts payable

    $3.32M
    ANTX annual accounts payable is $3.32 million

    Debt

    Total debt

    $0.00
    ANTX annual total debt is $0.00

    Total debt 1-year change

    0%
    ANTX annual total debt has remained unchanged year-on-year

    Long term debt

    $0.00
    ANTX annual long term debt is $0.00

    Short term debt

    $0.00
    ANTX annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    $81.85M
    ANTX annual stockholders equity is $81.85 million

    Book value

    $81.85M
    ANTX annual book value is $81.85 million

    Retained earnings

    -$205.78M
    ANTX annual retained earnings is -$205.78 million

    Working capital

    $76.02M
    ANTX annual working capital is $76.02 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$49.26M
    ANTX annual cash flow from operations is -$49.26 million

    Cash from operations 1-year change

    +7.56%
    ANTX annual cash flow from operations is up +7.56% year-on-year

    Cash from investing

    $54.59M
    ANTX annual cash flow from investing activities is $54.59 million

    Cash from investing 1-year change

    +226.14%
    ANTX annual cash flow from investing activities is up +226.14% year-on-year

    Cash from financing

    $372.00K
    ANTX annual cash flow from financing activities is $372.00 thousand

    Cash from financing 1-year change

    -99.56%
    ANTX annual cash flow from financing activities is down -99.56% year-on-year

    CAPEX

    CAPEX

    $0.00
    ANTX annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    ANTX annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$49.26M
    ANTX annual free cash flow is -$49.26 million

    Free cash flow 1-year change

    +7.56%
    ANTX annual free cash flow is up +7.56% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ANTX annual gross profit margin value is unknown

    Operating margin

    -
    ANTX annual operating profit margin value is unknown

    Net margin

    -
    ANTX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -44.47%
    ANTX annual return on assets is -44.47%

    ROE

    -49.69%
    ANTX annual return on equity is -49.69%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ANTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ANTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.46
    ANTX price to book ratio is 0.46

    PB ratio Sector rank

    23.83%
    ANTX price to book ratio is higher than 23.83% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ANTX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ANTX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -$31.49M
    ANTX enterprise value is -$31.49 million

    Enterprise value Sector rank

    3.52%
    ANTX enterprise value is higher than 3.52% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.80
    ANTX EV/EBITDA is 0.80

    EV/EBITDA Sector rank

    73.37%
    ANTX EV/EBITDA is higher than 73.37% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    8.43
    ANTX annual current ratio is 8.43

    Quick ratio

    8.43
    ANTX annual quick ratio is 8.43

    Leverage

    Debt to equity

    0.00
    ANTX annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ANTX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ANTX piotroski f-score value is unknown

    Altman Z-Score

    -2.25
    ANTX altman z-score is -2.25

    Analyst ratings

    Recent major analysts updates

    May 5, 25 JMP Securities
    Market Outperform
    Mar 26, 25 Citizens Capital Markets
    Market Outperform
    Feb 25, 25 Citizens Capital Markets
    Market Outperform
    Feb 3, 25 JMP Securities
    Market Outperform
    Nov 19, 24 JMP Securities
    Market Outperform
    Nov 18, 24 TD Cowen
    Hold
    Aug 9, 24 JMP Securities
    Market Outperform
    Jul 3, 24 Leerink Partners
    Outperform
    May 16, 24 Evercore ISI Group
    In-Line
    Apr 2, 24 JMP Securities
    Market Outperform

    Institutional Ownership

    Screeners with ANTX included

    US stocks
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Companies with buyback
    Biotech Companies
    Ex Dividend dates calendar
    • What is the ticker symbol for AN2 Therapeutics, Inc.?
    • Does AN2 Therapeutics, Inc. pay dividends?
    • What sector is AN2 Therapeutics, Inc. in?
    • What industry is AN2 Therapeutics, Inc. in?
    • What country is AN2 Therapeutics, Inc. based in?
    • When did AN2 Therapeutics, Inc. go public?
    • Is AN2 Therapeutics, Inc. in the S&P 500?
    • Is AN2 Therapeutics, Inc. in the NASDAQ 100?
    • Is AN2 Therapeutics, Inc. in the Dow Jones?
    • When was AN2 Therapeutics, Inc.'s last earnings report?
    • When does AN2 Therapeutics, Inc. report earnings?

    What is the ticker symbol for AN2 Therapeutics, Inc.?

    The ticker symbol for AN2 Therapeutics, Inc. is NASDAQ:ANTX

    Does AN2 Therapeutics, Inc. pay dividends?

    No, AN2 Therapeutics, Inc. does not pay dividends

    What sector is AN2 Therapeutics, Inc. in?

    AN2 Therapeutics, Inc. is in the Healthcare sector

    What industry is AN2 Therapeutics, Inc. in?

    AN2 Therapeutics, Inc. is in the Biotechnology industry

    What country is AN2 Therapeutics, Inc. based in?

    AN2 Therapeutics, Inc. is headquartered in United States

    When did AN2 Therapeutics, Inc. go public?

    AN2 Therapeutics, Inc.'s initial public offering (IPO) was on March 25, 2022

    Is AN2 Therapeutics, Inc. in the S&P 500?

    No, AN2 Therapeutics, Inc. is not included in the S&P 500 index

    Is AN2 Therapeutics, Inc. in the NASDAQ 100?

    No, AN2 Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is AN2 Therapeutics, Inc. in the Dow Jones?

    No, AN2 Therapeutics, Inc. is not included in the Dow Jones index

    When was AN2 Therapeutics, Inc.'s last earnings report?

    AN2 Therapeutics, Inc.'s most recent earnings report was on August 14, 2025

    When does AN2 Therapeutics, Inc. report earnings?

    The date for AN2 Therapeutics, Inc.'s next earnings report has not been announced yet
    On this page